Newborn Screening for Duchenne Muscular Dystrophy: First Year Results of a Population-Based Pilot

Advancements in therapies for Duchenne muscular dystrophy (DMD) have made diagnosis within the newborn period a high priority. We undertook a consortia approach to advance DMD newborn screening in the United States. This manuscript describes the formation of the Duchenne Newborn Screening Consortium...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartnett, Michael J., Lloyd-Puryear, Michele A., Tavakoli, Norma P., Wynn, Julia, Koval-Burt, Carrie L., Gruber, Dorota, Trotter, Tracy, Caggana, Michele, Chung, Wendy K., Armstrong, Niki, Brower, Amy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589949/
https://www.ncbi.nlm.nih.gov/pubmed/36278620
http://dx.doi.org/10.3390/ijns8040050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589949/
https://www.ncbi.nlm.nih.gov/pubmed/36278620
http://dx.doi.org/10.3390/ijns8040050

Ejemplares similares